|
1
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Llovet JM and Bruix J: Molecular targeted
therapies in hepatocellular carcinoma. Hepatology. 48:1312–1327.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bogachek MV, De Andrade JP and Weigel RJ:
Regulation of epithelial-mesenchymal transition through SUMOylation
of transcription factors. Cancer Res. 75:11–15. 2015. View Article : Google Scholar
|
|
4
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Trimboli AJ, Fukino K, de Bruin A, Wei G,
Shen L, Tanner SM, Creasap N, Rosol TJ, Robinson ML, Eng C, et al:
Direct evidence for epithelial-mesenchymal transitions in breast
cancer. Cancer Res. 68:937–945. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ross SA, McCaffery PJ, Drager UC and De
Luca LM: Retinoids in embryonal development. Physiol Rev.
80:1021–1054. 2000.PubMed/NCBI
|
|
8
|
Feldman DR, Patil S, Trinos MJ, Carousso
M, Ginsberg MS, Sheinfeld J, Bajorin DF, Bosl GJ and Motzer RJ:
Progression-free and overall survival in patients with
relapsed/refractory germ cell tumors treated with single-agent
chemotherapy: Endpoints for clinical trial design. Cancer.
118:981–986. 2012. View Article : Google Scholar
|
|
9
|
Li M, Sun Y, Guan X, Shu X and Li C:
Advanced progress on the relationship between RA and its receptors
and malignant tumors. Crit Rev Oncol Hematol. 91:271–282. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Woo YJ and Jang KL: All-trans retinoic
acid activates E-cadherin expression via promoter hypomethylation
in the human colon carcinoma HCT116 cells. Biochem Biophys Res
Commun. 425:944–949. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zanetti A, Affatato R, Centritto F,
Fratelli M, Kurosaki M, Barzago MM, Bolis M, Terao M, Garattini E
and Paroni G: All-trans-retinoic acid modulates the plasticity and
inhibits the motility of breast cancer cells: Role of NOTCH1 and
transforming growth factor (TGFβ). J Biol Chem. 290:17690–17709.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chansri N, Kawakami S, Yamashita F and
Hashida M: Inhibition of liver metastasis by all-trans retinoic
acid incorporated into O/W emulsions in mice. Int J Pharm.
321:42–49. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Guan DX, Shi J, Gao H, Li JJ,
Zhao JS, Qiu L, Liu J, Li N, Guo WX, et al: All-trans retinoic acid
potentiates the chemotherapeutic effect of cisplatin by inducing
differentiation of tumor initiating cells in liver cancer. J
Hepatol. 59:1255–1263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rodriguez LG, Wu X and Guan JL:
Wound-healing assay. Methods Mol Biol. 294:23–29. 2005.
|
|
15
|
Bi Y, Huang J, He Y, Zhu GH, Su Y, He BC,
Luo J, Wang Y, Kang Q, Luo Q, et al: Wnt antagonist SFRP3 inhibits
the differentiation of mouse hepatic progenitor cells. J Cell
Biochem. 108:295–303. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang MH, Chen CL, Chau GY, Chiou SH, Su
CW, Chou TY, Peng WL and Wu JC: Comprehensive analysis of the
independent effect of twist and snail in promoting metastasis of
hepatocellular carcinoma. Hepatology. 50:1464–1474. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mima K, Hayashi H, Kuroki H, Nakagawa S,
Okabe H, Chikamoto A, Watanabe M, Beppu T and Baba H:
Epithelial-mesenchymal transition expression profiles as a
prognostic factor for disease-free survival in hepatocellular
carcinoma: Clinical significance of transforming growth factor-β
signaling. Oncol Lett. 5:149–154. 2013.
|
|
18
|
Yamada T, Yoshikawa M, Kanda S, Kato Y,
Nakajima Y, Ishizaka S and Tsunoda Y: In vitro differentiation of
embryonic stem cells into hepatocyte-like cells identified by
cellular uptake of indocyanine green. Stem Cells. 20:146–154. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kamo N, Yasuchika K, Fujii H, Hoppo T,
Machimoto T, Ishii T, Fujita N, Tsuruo T, Yamashita JK, Kubo H, et
al: Two populations of Thy1-positive mesenchymal cells regulate in
vitro maturation of hepatic progenitor cells. Am J Physiol
Gastrointest Liver Physiol. 292:G526–G534. 2007. View Article : Google Scholar
|
|
20
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mongan NP and Gudas LJ: Diverse actions of
retinoid receptors in cancer prevention and treatment.
Differentiation. 75:853–870. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Connolly RM, Nguyen NK and Sukumar S:
Molecular pathways: Current role and future directions of the
retinoic acid pathway in cancer prevention and treatment. Clin
Cancer Res. 19:1651–1659. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lo-Coco F, Ammatuna E, Montesinos P and
Sanz MA: Acute promyelocytic leukemia: Recent advances in diagnosis
and management. Semin Oncol. 35:401–409. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Arisi MF, Starker RA, Addya S, Huang Y and
Fernandez SV: All trans-retinoic acid (ATRA) induces
re-differentiation of early transformed breast epithelial cells.
Int J Oncol. 44:1831–1842. 2014.PubMed/NCBI
|
|
25
|
de Almeida Vasconcelos Fonseca EM, Chagas
CE, Mazzantini RP, Heidor R, Ong TP and Moreno FS: All-trans and
9-cis retinoic acids, retinol and beta-carotene chemopreventive
activities during the initial phases of hepatocarcinogenesis
involve distinct actions on glutathione S-transferase positive
preneoplastic lesions remodeling and DNA damage. Carcinogenesis.
26:1940–1946. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song K, Li W, Wang H, Wang H, Liu T, Ning
R and Wang L: Investigation of coculture of human adipose-derived
stem cells and mature adipocytes. Appl Biochem Biotechnol.
167:2381–2387. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zanatta G, Steffens D, Braghirolli DI,
Fernandes RA, Netto CA and Pranke P: Viability of mesenchymal stem
cells during electrospinning. Braz J Med Biol Res. 45:125–130.
2012. View Article : Google Scholar
|
|
28
|
Fan TT, Cheng Y, Wang YF, Gui SY, Chen FH,
Zhou Q and Wang Y: A novel all-trans retinoid acid derivative
N-(3-trifluoromethyl-phenyl)-retinamide inhibits lung
adenocarcinoma A549 cell migration through down-regulating
expression of myosin light chain kinase. Asian Pac J Cancer Prev.
15:7687–7692. 2014. View Article : Google Scholar
|
|
29
|
Zhou RJ, Liao WG, Yang ZZ, Min J and Xiao
Y: Effects and mechanisms of ATRA on proliferation, cell cycle of
lung carcinoma cellline A549. Acta Academiae Medicinae Militaris
Tertiae. 14:1399–1401. 2007.
|
|
30
|
Nitto T and Sawaki K: Molecular mechanisms
of the antileukemia activities of retinoid and arsenic. J Pharmacol
Sci. 126:179–185. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Okuno M, Kojima S, Matsushima-Nishiwaki R,
Tsurumi H, Muto Y, Friedman SL and Moriwaki H: Retinoids in cancer
chemoprevention. Curr Cancer Drug Targets. 4:285–298. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tania M, Khan MA and Fu J: Epithelial to
mesenchymal transition inducing transcription factors and
metastatic cancer. Tumour Biol. 35:7335–7342. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu Z, Jin ZY, Liu CH, Xie F, Lin XS and
Huang Q: MicroRNA-21 regulates biological behavior by inducing EMT
in human cholangiocarcinoma. Int J Clin Exp Pathol. 8:4684–4694.
2015.PubMed/NCBI
|
|
34
|
Ye Z, Zhou M, Tian B, Wu B and Li J:
Expression of lncRNA-CCAT1, E-cadherin and N-cadherin in colorectal
cancer and its clinical significance. Int J Clin Exp Med.
8:3707–3715. 2015.PubMed/NCBI
|
|
35
|
Zhou J, Tao D, Xu Q, Gao Z and Tang D:
Expression of E-cadherin and vimentin in oral squamous cell
carcinoma. Int J Clin Exp Pathol. 8:3150–3154. 2015.PubMed/NCBI
|
|
36
|
Ting HJ, Deep G, Jain AK, Cimic A,
Sirintrapun J, Romero LM, Cramer SD, Agarwal C and Agarwal R:
Silibinin prevents prostate cancer cell-mediated differentiation of
naive fibroblasts into cancer-associated fibroblast phenotype by
targeting TGF beta2. Mol Carcinog. 54:730–741. 2015. View Article : Google Scholar
|
|
37
|
Thaiparambil JT, Bender L, Ganesh T, Kline
E, Patel P, Liu Y, Tighiouart M, Vertino PM, Harvey RD, Garcia A,
et al: Withaferin A inhibits breast cancer invasion and metastasis
at sub-cytotoxic doses by inducing vimentin disassembly and serine
56 phosphorylation. Int J Cancer. 129:2744–2755. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee J, Hahm ER, Marcus AI and Singh SV:
Withaferin A inhibits experimental epithelial-mesenchymal
transition in MCF-10A cells and suppresses vimentin protein level
in vivo in breast tumors. Mol Carcinog. 54:417–429. 2015.
View Article : Google Scholar
|
|
39
|
Tian Q, Xue Y, Zheng W, Sun R, Ji W, Wang
X and An R: Overexpression of hypoxia-inducible factor 1α induces
migration and invasion through Notch signaling. Int J Oncol.
47:728–738. 2015.PubMed/NCBI
|
|
40
|
Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS,
Leem SH and Kim DG: Lipocalin-2 negatively modulates the
epithelial-to-mesenchymal transition in hepatocellular carcinoma
through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1
pathway. Hepatology. 58:1349–1361. 2013. View Article : Google Scholar : PubMed/NCBI
|
